427 related articles for article (PubMed ID: 27856776)
1. Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Winkelman JW; Armstrong MJ; Allen RP; Chaudhuri KR; Ondo W; Trenkwalder C; Zee PC; Gronseth GS; Gloss D; Zesiewicz T
Neurology; 2016 Dec; 87(24):2585-2593. PubMed ID: 27856776
[TBL] [Abstract][Full Text] [Related]
2. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Sun Y; van Valkenhoef G; Morel T
Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
[TBL] [Abstract][Full Text] [Related]
3. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.
Iftikhar IH; Alghothani L; Trotti LM
Eur J Neurol; 2017 Dec; 24(12):1446-1456. PubMed ID: 28888061
[TBL] [Abstract][Full Text] [Related]
5. The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.
Aurora RN; Kristo DA; Bista SR; Rowley JA; Zak RS; Casey KR; Lamm CI; Tracy SL; Rosenberg RS;
Sleep; 2012 Aug; 35(8):1039-62. PubMed ID: 22851801
[TBL] [Abstract][Full Text] [Related]
6. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)
Winkelmann J; Allen RP; Högl B; Inoue Y; Oertel W; Salminen AV; Winkelman JW; Trenkwalder C; Sampaio C
Mov Disord; 2018 Jul; 33(7):1077-1091. PubMed ID: 29756335
[TBL] [Abstract][Full Text] [Related]
7. ADMET considerations for restless leg syndrome drug treatments.
de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1247-61. PubMed ID: 22808933
[TBL] [Abstract][Full Text] [Related]
8. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
[TBL] [Abstract][Full Text] [Related]
9. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
Bogan RK
Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
[TBL] [Abstract][Full Text] [Related]
10. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
Geyer J; Bogan R
Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
[TBL] [Abstract][Full Text] [Related]
11. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
[TBL] [Abstract][Full Text] [Related]
12. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
[TBL] [Abstract][Full Text] [Related]
13. Restless legs syndrome: pathophysiology and modern management.
Nagandla K; De S
Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.
Dostal M; Weber-Schoendorfer C; Sobesky J; Schaefer C
Eur J Neurol; 2013 Sep; 20(9):1241-6. PubMed ID: 23083216
[TBL] [Abstract][Full Text] [Related]
15. Interventions for chronic kidney disease-associated restless legs syndrome.
Gopaluni S; Sherif M; Ahmadouk NA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010690. PubMed ID: 27819409
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome-current therapies and management of augmentation.
Trenkwalder C; Winkelmann J; Inoue Y; Paulus W
Nat Rev Neurol; 2015 Aug; 11(8):434-45. PubMed ID: 26215616
[TBL] [Abstract][Full Text] [Related]
17. Rotigotine transdermal patch: in restless legs syndrome.
Baldwin CM; Keating GM
CNS Drugs; 2008; 22(10):797-806. PubMed ID: 18788832
[TBL] [Abstract][Full Text] [Related]
18. Restless legs syndrome in the older adult: diagnosis and management.
Milligan SA; Chesson AL
Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
[TBL] [Abstract][Full Text] [Related]
19. New treatment options for the management of restless leg syndrome.
Toro BE
J Neurosci Nurs; 2014 Aug; 46(4):227-32. PubMed ID: 24992148
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
